About this episode

In this episode, Laura Carfang interviews Annick Pyfferoen about her journey with de novo metastatic breast cancer and her treatment experiences.

Love the podcast? Send us a text! In this episode of Breast Cancer Conversations, host Laura Carfang speaks with Annick Pyfferoen about her experience being diagnosed with de novo metastatic breast cancer and navigating several lines of treatment including targeted therapy, chemotherapy, a clinical trial attempt involving tumor-infiltrating lymphocytes, Enhertu, and Xeloda. She speaks openly about what it felt like to experience rapid progression and why having a plan, even one that may...

People in this episode

Host: Laura Carfang

Guest: Annick Pyfferoen

Topics covered

• metastatic breast cancer
• treatment options
• personal experience
• clinical trials
• targeted therapy
• chemotherapy

Keywords

• breast cancer
• metastatic
• treatment
• Enhertu
• Xeloda
• clinical trial
• personal story

Mentioned in this episode

Products: Enhertu, Xeloda, tumor-infiltrating lymphocytes

More episodes of Breast Cancer Conversations

• 299. The Messy Middle of Breast Cancer: Chemo, Surgery, Side Effects, and Survivorship with Jessica Thomas · May 31, 2026 · 27 min
• 298. The Truth About Cold Capping During Chemo · May 24, 2026 · 38 min
• 296. Inside Oligometastatic Breast Cancer: Kacie Flaherty and Joyce Dini on Treatment, Grief, and Joy · May 10, 2026 · 29 min

Explore listener stats, chart rankings, contacts and more on the Breast Cancer Conversations podcast page.